Journals / Türk Göğüs Kalp Damar Cerrahisi Dergisi / 2012 / Cilt: 20 - Sayı: 4

The gastrocnemius muscle hematoma arising from warfarin use: The importance of genotype analysis in hematomas of atypical localization

Warfarin kullanımından kaynaklanan gastroknemius kası hematomu: Atipik yerleşimli hematomlarda genotip analizinin önemi

Pages
929–931
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article, we report a-41-year-old female case with hematoma in the gastrocnemius muscle due to low doses (i.e. 1.25 mg) of warfarin every other day.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Warfarin is an effective anticoagulant which is used for the prevention of arterial and venous thrombosis.
📊
Key Findings & Data:Currently, this type of oral anticoagulant drugs are often used with various indications and rarely leads life-threatening bleeding.
💡
Conclusion & Impact:In this article, we report a-41-year-old female case with hematoma in the gastrocnemius muscle due to low doses (i.e. 1.25 mg) of warfarin every other day.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Warfarin is an effective anticoagulant which is used for the prevention of arterial and venous thrombosis. Currently, this type of oral anticoagulant drugs are often used with various indications and rarely leads life-threatening bleeding. Although bleeding into the gastrocnemius muscle, is usually associated with trauma, it may very rarely result from warfarin overdose. In this article, we report a-41-year-old female case with hematoma in the gastrocnemius muscle due to low doses (i.e. 1.25 mg) of warfarin every other day.

Özet

Warfarin, arteriyel ve venöz trombozların önlenmesinde kullanılan antikoagülan etkili bir ilaçtır. Günümüzde, bu tip oral antikoagülan ilaçlar çeşitli endikasyonlar ile sıklıkla kullanılmakta ve nadiren hayatı tehdit eden düzeyde kanamalara da yol açabilmektedir. Gastroknemius kası içine kanama genellikle travmaya bağlı olmasına karşın, çok nadiren de warfarin doz aşımına bağlı olarak ortaya çıkabilmektedir. Bu yazıda, gün aşırı 1.25 mg gibi oldukça düşük dozda warfarin kullanımına bağlı gastroknemius kası hematomu gelişen 41 yaşındaki bir kadın olgu sunuldu

🔖

Cite This Article

YAVUZ, C., YAZICI, S., ATILGAN, S., ÖNTÜRK, E. T., ARITÜRK, Z. A. (2022). The gastrocnemius muscle hematoma arising from warfarin use: The importance of genotype analysis in hematomas of atypical localization. Türk Göğüs Kalp Damar Cerrahisi Dergisi, Cilt: 20 - Sayı: 4, 929–931. https://ajindex.com/articles/624615

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Hirsh J, Dalen J, Anderson DR, Poller L, Bussey H, Ansell J, et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 2001;119:8S-21S. 2.Moyer TP, O'Kane DJ, Baudhuin LM, Wiley CL, Fortini A, Fisher PK, et al. Warfarin sensitivity genotyping: a review of the literature and summary of patient experience. Mayo Clin Proc 2009;84:1079-94. 3.Narcı H, Türk E, Uğur M, Karagülle E. Rectus Sheath hematoma mimicking acute abdominal pain. Cukurova Med J 2012;37:243- 46. 4.Dabbert O, Freeman DG, Weis AJ. Spinal meningeal hematoma, warfarin therapy, and chiropractic adjustment. JA MA 1970;214:2058. 5.Yaşa MH, Çildağ S, Taşkın F, Şen S, Yükselen V, Karaman C ve ark. Kumadine bağlı olarak gelişen intramural özofagus hematomu: Olgu sunumu. Akademik Gastroenteroloji Dergisi 2006;5:140-3. 6.Wang L, McLeod HL, Weinshilboum RM. Genomics and drug response. N Engl J Med 2011;364:1144-53. 7.Manolopoulos VG, Ragia G, Tavridou A. Pharmacogenetics of coumarinic oral anticoagulants. Pharmacogenomics 2010;11:493- 6. 8.Flockhart DA, O'Kane D, Williams MS, Watson MS, Flockhart DA, Gage B, et al. Pharmacogenetic testing of CYP2C9 and VKORC1 alleles for warfarin. Genet Med 2008;10:139-50. 9.Epstein RS, Moyer TP, Aubert RE, O Kane DJ, Xia F, Verbrugge RR, et al. Warfarin genotyping reduces hospitalization rates results from the MM-WES (Medco- Mayo Warfarin Effectiveness study). J Am Coll Cardiol 2010;55:2804-12.